Ototoxic reaction to erythromycin.
We report a case of bilateral hearing loss in a patient treated with intravenous erythromycin lactobionate. The ototoxic reaction occurred despite the patient's having normal renal and hepatic function and the fact that serum erythromycin levels were within the predicted normal range. In addition to hearing loss, a marked labyrinthic hyporreflexia was also observed. Hearing loss improved after the treatment was discontinued, but labyrinthic abnormalities persisted suggesting that erythromycin had caused a permanent vestibular damage.
Agustí
C
C
Department of Pneumology, Hospital Clinic, Faculty of Medicine, Barcelona, Spain.
Ferrán
F
F
Gea
J
J
Picado
C
C
D004917:Erythromycin / Q000009:adverse effects / Q000031:analogs & derivatives*; D006312:Hearing Loss, Bilateral / Q000139:chemically induced*; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged
C010948:erythromycin lactobionate; D004917:Erythromycin